跳至主要内容
临床试验/ISRCTN85177142
ISRCTN85177142进行中(未招募)未知

The impact of virtual reality-based exercise in the rehabilitation of people aged 60+ without neurodegenerative and mental disorders, in people aged 60+with Alzheimer's disease and in people of different ages suffering from schizophrenia.

Akademii Wychowania Fizycznego im. Jerzego Kukuczki w Katowicach0 个研究点目标入组 180 人开始时间: 2023年3月14日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
180

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Clinical trial no. 1
  • 1.1. Women and men aged = 60,
  • 1.2. Written consent to participate in the study,
  • 1.3. The ability to understand and follow the therapist's instructions,
  • 1.4. Everyday functional efficiency assessed on the Barthel index above 20 points,
  • 1.5. Cognitive efficiency assessed using the mini-mental state examination test, at the level of 26 - 30 points.
  • Clinical trial no. 2
  • 2.1. Women and men aged = 60,
  • 2.2. I or II stage of Alzheimer's disease,
  • 2.3. Written consent from the participant or his legal health care provider to participate in the study,
  • 2.4. The ability to understand and follow the therapist's instructions,
  • 2.5. Everyday functional efficiency assessed on the Barthel index above 20 points,
  • 2.6. Cognitive efficiency assessed using the mini-mental state examination test at the level of 11 - 24 points.
  • Clinical trial no. 3
  • 3.1. Women and men aged = 18,
  • 3.2. Clinically confirmed schizophrenia for at least 5 years, with predominance of negative symptoms,
  • 3.3. Unchanged pharmacotherapy for at least 3 months,
  • 3.4. Written consent from the patient or his legal medical provider to participate in the study,
  • 3.5. The ability to understand and follow the therapist's instructions,
  • 3.6. Everyday functional efficiency assessed on the Barthel index above 20 points,
  • 3.7. Cognitive efficiency assessed using the mini-mental state examination test at the level of 19 - 24 points.

排除标准

  • Clinical trial no. 1
  • 1.1. Contraindications to the exercises applied in the study,
  • 1.2. Neurodegenerative and mental diseases,
  • 1.3. Diseases of the nervous system (neuropathy, stroke, damage to the cerebellum, inner ear and labyrinth of the ear, Parkinson's disease),
  • 1.4. Illnesses and diseases of the musculoskeletal system that disturb the balance of the body and the mobility of the limbs.
  • Clinical trial no. 2
  • 2.1. Contraindications to the exercises applied in the study,
  • 2.2. III stage of Alzheimer's disease;
  • 2.3. Diseases of the nervous system (neuropathy, stroke, damage to the cerebellum, inner ear and labyrinth of the ear, parkinson's disease and others affecting functional efficiency and posture control),
  • 2.4. Illnesses and diseases of the musculoskeletal system that disturb the balance of the body and the mobility of the limbs.
  • Clinical trial no. 3
  • 3.1. Contraindications to the exercises applied in the study,
  • 3.2. Diseases of the nervous system and sense organs (neuropathy, stroke, damage to the cerebellum, inner ear and labyrinth of the ear, parkinson's disease and others affecting functional efficiency),
  • 3.3. Illnesses and diseases of the musculoskeletal system that impair functional efficiency.

研究者

发起方
Akademii Wychowania Fizycznego im. Jerzego Kukuczki w Katowicach

相似试验